Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA

Conditions: Androgenetic Alopecia Interventions: Drug: PP405 0.05% Topical Gel; Drug: PP405 Topical Vehicle Gel Sponsors: Pelage Pharmaceuticals, Inc. Not yet recruiting

Source: ClinicalTrials.gov - May 1, 2024 Category: Research Source Type: clinical trials